Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether budesonide or mesalazine is more active in the treatment of collagenous colitis.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Dr. Falk Pharma GmbH
NCT03658993 · Collagenous Colitis
NCT01504048 · Chronic Diarrhoea, Lymphocytic Colitis, and more
NCT00180076 · Collagenous Colitis
Center of digestive diseases
Hamburg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions